Align Technology (ALGN) Stock
NASDAQ · ALGN
144.54
Fundamentals
Market cap
$10.43B
Price / Earnings ratio
25.0x
Price / Sales ratio
2.5x
Price / Book ratio
2.4x
Return on assets
7.0%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.00%
Debt / Equity ratio
N/A
Recent news

MarketBeat
Align Technology Sees Invisalign Growth Runway Despite Consumer Headwinds
NeutralALGNSeptember 18, 2026
MarketBeatNeutral
Align Technology Sees Invisalign Growth Runway Despite Consumer Headwinds
ALGN

Zacks Investment Research
Should You Continue to Hold ALGN Stock in Your Portfolio?
NeutralALGNSeptember 14, 2026
Zacks Investment ResearchNeutral
Should You Continue to Hold ALGN Stock in Your Portfolio?
ALGN

Business Wire
Align Technology to Speak at Upcoming Financial Conference
NeutralALGNSeptember 8, 2026
Business WireNeutral
Align Technology to Speak at Upcoming Financial Conference
ALGN

Business Wire
Quentin Blackford to Join Align Technology Board of Directors
NeutralALGNAugust 31, 2026
Business WireNeutral
Quentin Blackford to Join Align Technology Board of Directors
ALGN
Technicals
OscillatorsNeutral5 Indicators
Moving AveragesStrong Sell12 Indicators
Analyst Ratings
Strong Sell0
Sell0
Neutral1
Buy1
Strong Buy0
Financials
Performance
Revenue
Net income
Net margin %
2022
2023
2025
5B3B2B0
Debt & Balance Sheet
Total assets
Total liabilities
2022
2023
2025
7B5B2B0
Revenue to Profit
2025$4.0B
Revenue$0.0
Cost of revenue$0.0
Gross profit$0.0
Operating expenses$410.4M
Net incomeEarnings
EPS forecast
Actual EPS
$2.49
$2.39
Q2FY25
$2.61
$2.20
Q3FY25
$2.77
Q4FY25
$2.17
Q1FY26
$2.12
Q2FY26
The market is expecting earnings per share of $2.12 for this quarter. The company has not yet shared when it is announcing earnings.
% positive news of 10 articles
published over the past 14 days
Latest news

MarketBeat
Align Technology Sees Invisalign Growth Runway Despite Consumer Headwinds
NeutralALGNSeptember 18, 2026
MarketBeatNeutral
Align Technology Sees Invisalign Growth Runway Despite Consumer Headwinds
ALGN

Zacks Investment Research
Should You Continue to Hold ALGN Stock in Your Portfolio?
NeutralALGNSeptember 14, 2026
Zacks Investment ResearchNeutral
Should You Continue to Hold ALGN Stock in Your Portfolio?
ALGN

Business Wire
Align Technology to Speak at Upcoming Financial Conference
NeutralALGNSeptember 8, 2026
Business WireNeutral
Align Technology to Speak at Upcoming Financial Conference
ALGN

Business Wire
Quentin Blackford to Join Align Technology Board of Directors
NeutralALGNAugust 31, 2026
Business WireNeutral
Quentin Blackford to Join Align Technology Board of Directors
ALGN

Zacks Investment Research
Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?
NeutralALGNAugust 28, 2026
Zacks Investment ResearchNeutral
Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?
ALGN

Zacks Investment Research
How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook
NeutralALGNAugust 17, 2026
Zacks Investment ResearchNeutral
How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook
ALGN

Zacks Investment Research
Should Investors Buy Align as Growth Meets Valuation and Demand Risks?
NeutralALGNAugust 14, 2026
Zacks Investment ResearchNeutral
Should Investors Buy Align as Growth Meets Valuation and Demand Risks?
ALGN

Business Wire
Align Technology Prevails in China Patent Infringement Action Against Angelalign
NeutralALGNAugust 12, 2026
Business WireNeutral
Align Technology Prevails in China Patent Infringement Action Against Angelalign
ALGN

Zacks Investment Research
ALGN Stock Up Post Q2 Earnings and Revenue Beat, Margins Rise
NeutralALGNJuly 30, 2026
Zacks Investment ResearchNeutral
ALGN Stock Up Post Q2 Earnings and Revenue Beat, Margins Rise
ALGN

Zacks Investment Research
ALGN Q2 Earnings Call Highlights Digital Growth Push
NeutralALGNJuly 30, 2026
Zacks Investment ResearchNeutral
ALGN Q2 Earnings Call Highlights Digital Growth Push
ALGN
About Align Technology
Align Technology is a manufacturer of 3D digital scanners and clear aligners used in orthodontics. It is headquartered in San Jose, California; it manufactures the aligners in Juarez, Mexico and its scanners in Israel and China.
SectorHealthcare
IndustryMedical Devices
Employees20,435
CEOMr. Joseph M. Hogan
IPO DateJan 26, 2001
HeadquartersTempe, AZ
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Joseph M. Hogan | President, CEO & Director | 1957 |
| Mr. John F. Morici | CFO & Executive VP of Global Finance | 1967 |
| Mr. Zelko Relic | Executive VP & CTO | 1965 |
| Ms. Shirley Stacy | Vice President of Corporate Communications & Investor Relations | — |
| Richardson Jaime Holte | Executive Vice President of Global Human Resources | — |
| Ms. Sreelakshmi Kolli | Executive VP and Chief Product & Digital Officer | 1975 |
| Mr. Srini Kaza | Executive Vice President of Research & Development | — |
| Dr. Mitra Derakhshan | Executive VP, Chief Clinical Officer, Global Treatment Planning & Clinical Services | — |
| Mr. David Carr | Executive VP and MD of EMEA | — |
| Mr. Frank Quinn | Executive VP & MD of Americas Region | — |
Fundamentals
Valuation
Market cap$10.43B
Price-to-sales ratio2.50
Price-to-book value2.44
Price-earnings ratio25.00
Return on Equity11.00%
Return on Sales15.00%
Return on Assets7.00%
PEG ratio0.62
Earnings Per Share
Earnings Per Share$5.76
Income Statement
Average volume903,115
EBITDA$888.91M
1 year high (52w)$200.44
1 year low (52w)$122.00
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A
Technicals
OscillatorsNeutral5 Indicators
Moving AveragesStrong Sell12 Indicators
What the experts say
2 Wall Street Analyst Ratings
HOLD
50% Buy
50% Hold
0% Sell
Target price
$199.00
Est return
35.59%
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -1.1 | -5.7 | -7.5 | +9.1 | ||||||||
| 2022 | -23.6 | +0.6 | -13.0 | -35.1 | -10.1 | -10.7 | +13.6 | -13.8 | -15.7 | -9.9 | +1.9 | +4.5 |
| 2023 | +27.1 | +9.5 | +8.3 | -0.6 | -10.9 | +19.0 | +9.7 | -1.7 | -18.6 | -38.4 | +16.7 | +24.3 |
| 2024 | -0.6 | +10.6 | +9.3 | -11.7 | -9.6 | -5.1 | -2.8 | +3.9 | +12.3 | -16.4 | +11.6 | -10.9 |
| 2025 | +5.1 | -13.3 | -9.3 | +9.6 | +2.4 | +6.1 | -33.6 | +4.0 | -8.7 | +8.1 | +6.3 | +6.4 |
| 2026 | +4.5 | +16.2 | -9.3 | +1.9 | -2.2 | -0.7 | -6.8 | -7.6 | -5.3 |



